Payment Assistance and Savings Program Extended for the Eversense E3 CGM

Ascensia Diabetes Care and Senseonics have extended their Eversense Payment Assistance and Simple Savings (PASS) program—aimed to help people in the U.S. more affordably access the Eversense E3 continuous glucose monitor (CGM).

Under the PASS program, eligible individuals will pay $99 out of pocket for an unlimited number of six-month Eversense E3 systems.

This comes to an average monthly cost of $16.50 (excluding the costs of insertion and removal).

For up to 180 days, the Eversense E3 CGM System is indicated for use to continually measure blood-sugar levels in adults 18 years and older with diabetes.

The system can also be used in place of finger-stick blood-sugar measurements to make diabetes treatment decisions.

“Traditional, short-term CGMs don’t work for everyone, and we are proud to bring a truly unique CGM option in Eversense E3 to people with diabetes,” said Rudy Thoms, VP, CGM Commercial U.S. at Ascensia Diabetes Care. “We are significantly extending the Eversense PASS program to provide major savings for people in the U.S., beyond when they first try the 6-month CGM to their subsequent Eversense E3 CGM systems.

“We believe that long-term CGMs are the future, and so we are pleased to further improve access to and affordability of Eversense, allowing more people to experience the future today.”

Eligibility & Exclusions Overview

To be eligible, a person must have a commercial insurance plan—with or without coverage for the Eversense E3 CGM.

They must also meet medical coverage criteria for CGM as indicated by their insurance provider.

To learn more about Eversense E3, go to www.ascensiadiabetes.com/eversense.

To learn more about the PASS program and find out if they are eligible, go to https://www.ascensiadiabetes.com/eversense/coverage/patient-assistance-program-information/.

WRITTEN BY Daniel Trecroci, POSTED 03/15/24, UPDATED 03/15/24

Dan has written about diabetes for more than 20 years. He was one of Diabetes Health's first recruits, and throughout his 10 + years as Managing Editor he wrote/published thousands of articles and helped establish Diabetes Health as the premiere resource for people with diabetes. He later became the Content Manager for OneTouchGold—Johnson & Johnson/LifeScan’s official digital publication for its metering-technology customers. Under his leadership, OneTouchGold received the Web Marketing Association’s award for “Best Health & Wellness" web site. Dan has an also written for the Diabetes Research Institute, dLife, diaTribe, Healthline, CareDx, Pendulum Therapeutics, and Hero Bread.